UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Clinical trials for UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA explained in plain language.
Never miss a new study
Get alerted when new UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA trials appear
Sign up with your email to follow new studies for UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New malaria drug shows promise in early trial
Disease control CompletedThis study tested a new anti-malarial drug called INE963 in 52 adults with uncomplicated Plasmodium falciparum malaria. The goal was to see how quickly the drug cleared the malaria parasite from the blood and how well it was tolerated. Participants took the drug by mouth and were…
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 08:03 UTC
-
New malaria combo shows promise in kids
Disease control CompletedThis study tested a new combination of two drugs, KAF156 and lumefantrine, in 295 children aged 6 months to 18 years with uncomplicated malaria. The goal was to see if the treatment works well and is safe, and to offer a new option that may help prevent drug resistance. The study…
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:52 UTC
-
New malaria pill matches leading treatment in large global trial
Disease control CompletedThis study tested a new malaria drug, KLU156, against the standard treatment Coartem in over 1,700 adults and children with uncomplicated malaria. The goal was to see if KLU156 works as well and is safe. Results showed KLU156 is non-inferior to Coartem, meaning it is a comparable…
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New malaria combo shows promise in clearing parasites
Disease control CompletedThis study tested a combination of two anti-malarial drugs, cipargamin and KLU156, in 60 people aged 12 and older with uncomplicated Plasmodium falciparum malaria. The main goal was to see if the treatment could clear the malaria parasite from the blood by day 29 without the infe…
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:54 UTC